 Axa decreased its stake in shares of Five Prime Therapeutics Inc NASDAQ:FPRX by 54.0 during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 146,371 shares of the biotechnology companys stock after selling 171,905 shares during the period. Axa owned 0.40 of Five Prime Therapeutics worth 672,000 as ... 